Last week, a musician had his brain tumor removed while fully conscious during a nine-hour surgery that took place in Italy. During the operation, which was carried out at the Paideia International Hospital in Rome, the 35-year old musician played his saxophone. This helped the surgeon map out different functions of the brain as he operated.
Dr. Christian Brogna, the neurosurgeon who performed the operation, stated in an interview that there were no negative effects observed in the patient after the tumor was successfully removed. Brogna led a team of highly qualified specialists during the operation, which used state-of-the-art technology.
The brain tumor was located in a complex area of the brain, and the patient being left-handed complicated the surgery even more. This meant that the surgeons had to be more tactful in extraction to prevent any damage.
At different times during the operation, the patient played the Italian national anthem and the theme song from the 70s movie, “Love Story.” The patient had emphasized how important it was that his musical ability be preserved, which was why he was kept awake and playing throughout the whole operation.
Brogna explained that playing an instrument was a high cognitive function because it involved not only understanding music but also interacting with one’s instrument, exercising one’s memory and coordinating using both hands as well as counting. The neurosurgeon prepared for the complex surgery in advance, noting that every patient has a unique brain, which meant that the surgeon needed to know the patient in detail as well as learn what functions were most important to preserve.
To prepare, the surgeon met with the patient and the medical team six or seven times before the surgery.
Brogan explained that during brain surgery, it is important to ensure that no damage is done to an individual’s personality, how they function daily and how they feel about emotions; he noted that protecting the patient’s wishes was a primary objective. He added that preparation also gives surgeons time to ensure that the patient is aware of everything the procedure entails. This is in addition to allowing surgeons to reassure patients and instruct them on what not to do during the operation.
Following the surgery’s success, Brogna acknowledged that he was proud that the patient had been able to resume life with no hitches, adding that every surgery also advances his knowledge in this particular branch of medicine.
As companies such as CNS Pharmaceuticals Inc. (NASDAQ: CNSP) register success in their quest to commercialize superior formulations targeting brain cancer, the need for invasive procedures to remove malignant tumors could decrease as new drugs score higher success rates in stopping tumors from spreading.
NOTE TO INVESTORS: The latest news and updates relating to CNS Pharmaceuticals Inc. (NASDAQ: CNSP) are available in the company’s newsroom at https://ibn.fm/CNSP
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to millions of social media followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)
For more information, please visit https://www.biomedwire.com
San Francisco, California
BioMedWire is part of the InvestorBrandNetwork.